Prenatal Anxiety Screening in OB and Midwifery Practice

Most PMAD screening protocols are designed for the postpartum period. The six-week visit, the well-child check, the pediatric intake: the clinical infrastructure for identifying perinatal mental health problems is largely postpartum-facing. Prenatal anxiety, which affects approximately 15 to 20% of pregnant patients and independently predicts postpartum PMAD, receives comparatively little attention in clinical workflows.

The consequence is predictable. Patients with clinically significant prenatal anxiety reach the postpartum period without any screening or support history. When postpartum symptoms emerge, they appear to the clinical team as a new problem, when in fact they often represent a continuation of something that was present and screenable months earlier.

The prenatal visit is frequently the only clinical window that exists before postpartum crisis. OBs and midwives who screen for anxiety during pregnancy are better positioned to identify patients early, initiate support before delivery, and coordinate care across the perinatal period.

---

Prevalence and What It Predicts

Prenatal anxiety affects 15 to 20% of pregnant patients across population studies, with higher rates in patients with prior anxiety disorders, prior pregnancy loss, or significant life stressors during pregnancy. Unlike the baby blues, prenatal anxiety does not resolve spontaneously after delivery.

The clinical significance extends beyond the pregnancy itself. Prenatal anxiety is one of the strongest predictors of postpartum anxiety and postpartum depression. Patients with untreated moderate-to-severe prenatal anxiety are two to three times more likely to develop a postpartum PMAD than those without prenatal anxiety. Prenatal screening is not only useful for identifying current distress; it identifies patients at elevated risk for the postpartum period and creates an opportunity to support them before symptoms escalate.

---

The Right Tool: GAD-7 Over EPDS for Anxiety

The EPDS is the most commonly administered perinatal mental health screen and is appropriate for depression screening across the perinatal period. It contains three items (questions 3, 4, and 5) that capture anxiety-adjacent symptoms, and some practices use these as an anxiety subscale. However, the EPDS anxiety subscale was not validated as a standalone anxiety screen and does not comprehensively assess the symptom domains that define generalized anxiety disorder.

The GAD-7 (Generalized Anxiety Disorder 7-item scale) is the preferred tool for anxiety-specific screening in pregnant populations. It assesses the core features of anxiety across seven items scored 0 to 3, yielding a total score of 0 to 21.

GAD-7 scoring thresholds:

• 5-9: Mild anxiety: monitor, psychoeducation, rescreen at next visit
• 10-14: Moderate anxiety: referral indicated; warm handoff preferred
• 15-21: Severe anxiety: prompt referral; functional impairment is likely

The GAD-7 can be administered alongside the EPDS or independently. Practices that administer only the EPDS should supplement with GAD-7 screening for patients who present with anxiety-predominant symptoms or who have a prior anxiety history, even if their EPDS score does not indicate concern.

---

What Clinically Significant Prenatal Anxiety Looks Like

Normal pregnancy worry is common and does not require clinical intervention. Expecting parents worry about fetal health, labor outcomes, and their readiness for parenthood. This worry is episodic, responsive to accurate information, and does not impair functioning in ways that are clinically observable.

Clinical prenatal anxiety operates differently. The distinguishing features are persistence, reassurance-resistance, and functional impact.

Reassurance-resistance is the most diagnostically useful clinical marker. A patient whose anxiety does not meaningfully decrease when you provide accurate, positive clinical information, across multiple encounters, is not experiencing normal worry. Her anxiety is not responding to evidence because it is driven by a cognitive pattern that evidence does not correct. This is the hallmark of clinical anxiety.

Functional impact is the other key marker. Look for:

• Disrupted sleep that goes beyond what physical discomfort explains. A patient at 20 weeks who is not sleeping because she cannot stop worrying about delivery outcomes is describing clinically significant anxiety, not pregnancy discomfort.
• Avoidance of specific clinical information. Some patients with prenatal anxiety avoid reading test results, refuse to discuss contingencies, or disengage from conversations about birth planning because engagement increases distress rather than reducing it.
• Somatic symptoms with no other explanation: persistent gastrointestinal distress, tension headaches, and muscle tightness that track with worry rather than with physical pregnancy changes.
• Catastrophic thinking that recurs despite normal findings. A patient who remains convinced that something is wrong with her baby after a normal anatomy scan, and who repeats this concern at subsequent visits, is describing anxiety that is not responding to clinical reality.

---

When to Screen

First prenatal visit: Baseline screening at the first visit serves two purposes. It identifies patients with pre-existing anxiety disorders that may worsen during pregnancy, and it establishes a baseline for comparison at later visits. Patients who screen positive at baseline should be referred for mental health support early in the pregnancy, not deferred until the postpartum period.

28 to 32 weeks: Third-trimester screening captures patients whose anxiety develops or intensifies as delivery approaches. Anticipatory anxiety about labor, pain, and loss of control peaks in the third trimester, and many patients who screened negative at baseline will screen positive at this point. This is the rescreening window that most protocols omit.

Higher-risk populations warrant more frequent screening throughout: Patients with a prior anxiety disorder or prior PMAD, patients who have experienced pregnancy loss or a prior traumatic delivery, and patients with significant life stressors during pregnancy should be screened at every trimester, not just at standard windows.

---

Responding to a Positive Screen

The response to a positive GAD-7 should be tiered by severity.

Mild (GAD-7 5-9): Brief psychoeducation about prenatal anxiety, normalization of the screening process, and a plan to rescreen at the next visit. Some patients in this range will improve without referral; others will cross into moderate severity at the next screen. The purpose of this tier is to monitor, not to wait indefinitely.

Moderate (GAD-7 10-14): A referral to outpatient perinatal mental health is indicated. Cognitive behavioral therapy for anxiety is the first-line treatment and is highly effective in pregnant populations. A warm handoff, where a staff member facilitates direct contact between the patient and the mental health intake team during the visit, produces substantially higher referral completion rates than a paper referral alone.

Severe (GAD-7 15 and above): Prompt referral with same-day or next-day contact expected. Patients in this range have significant functional impairment. Discuss with the patient whether she has existing mental health support and, if not, prioritize rapid connection to care. For patients who are candidates for medication, SSRIs initiated during pregnancy for anxiety carry a well-established safety profile; consultation with the patient's prescriber or a perinatal psychiatrist is appropriate for moderate-to-severe presentations.

For guidance on making a referral and communicating clinical information to the receiving provider, see when and how to refer perinatal patients for mental health support.

Phoenix Health provides perinatal mental health support via telehealth and accepts referrals from OB and midwifery practices. For referral coordination and partnership inquiries, visit our referral and partnerships page.

---

FAQ

What screening tool is recommended for prenatal anxiety in obstetric practice

The GAD-7 is the preferred tool for prenatal anxiety screening. The EPDS is commonly used for perinatal mental health screening, but its anxiety-related items form a subscale, not a validated standalone anxiety screen. The GAD-7 directly assesses generalized anxiety severity with a 7-item scale scored 0-21. Scores of 5-9 indicate mild anxiety, 10-14 indicate moderate anxiety, and 15 or higher indicate severe anxiety warranting immediate clinical assessment and referral. At a threshold of 10 or higher, the GAD-7 has strong sensitivity and specificity for identifying clinically significant anxiety in pregnant populations.

How is clinically significant prenatal anxiety distinguished from normal pregnancy worry

Normal pregnancy worry is episodic, responsive to reassurance, and does not impair functioning. Clinically significant prenatal anxiety is persistent, does not resolve with information or reassurance, and produces functional impact: disrupted sleep, avoidance of clinical information, somatic symptoms, and catastrophic thinking that recurs despite normal findings. The clinical marker is reassurance-resistance: a patient whose anxiety is not meaningfully reduced by accurate clinical information, across multiple encounters, has crossed from normal concern into clinical anxiety.

At which prenatal visits should anxiety screening be administered

Screening at the first prenatal visit establishes a baseline and identifies patients with pre-existing anxiety disorders that may worsen during pregnancy. Rescreening at 28 to 32 weeks captures patients whose anxiety develops or intensifies in the third trimester, when anticipatory anxiety about labor and delivery peaks. Patients who screen positive at any point and are receiving support should be rescreened at subsequent visits to track response. Patients with a history of anxiety disorder or prior PMAD warrant closer screening frequency throughout the pregnancy, regardless of initial scores.

What should an OB or midwife do when a prenatal patient screens positive for anxiety

The response depends on severity. A GAD-7 score of 5-9 warrants brief psychoeducation and a plan to rescreen at the next visit. Scores of 10-14 indicate moderate anxiety and warrant a referral to outpatient perinatal mental health, with a warm handoff preferred over a paper referral. Scores of 15 or higher indicate severe anxiety and warrant prompt referral, often with same-day or next-day contact with the mental health provider. For any patient with prenatal anxiety, the referring provider should document GAD-7 scores and share them with the receiving therapist or prescriber.